Case details

Court: ded
Docket #: 1:15-cv-01008
Case Name: Purdue Pharma L.P. et al v. Actavis Laboratories FL Inc.
PACER case #: 58159
Date filed: 2015-11-03
Assigned to: Judge Gregory M. Sleet
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Purdue Pharma L.P.
Plaintiff
 
Jack B. Blumenfeld
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: jbbefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Rodger Dallery Smith , II
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 351-9205
Email: rdsefiling@mnat.com
ATTORNEY TO BE NOTICED
Purdue Pharmaceuticals L.P.
Plaintiff
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Rodger Dallery Smith , II
(See above for address)
ATTORNEY TO BE NOTICED
Actavis Laboratories FL Inc.
Defendant

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2015-11-03 1 0 COMPLAINT filed against Actavis Laboratories FL Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1820182.) - filed by Purdue Pharmaceuticals L.P., Purdue Pharma L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/03/2015)
2015-11-03 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 11/03/2015)
2015-11-03 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/22/2015. Date of Expiration of Patent: 08/24/2027.Thirty Month Stay Deadline: On or about 12/24/2017. (dmp, ) (Entered: 11/03/2015)
2015-11-03 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,056,052 B1; 9,060,940 B2; 9,084,816 B2; 9,095,614 B2;. (dmp, ) (Entered: 11/03/2015)
2015-11-03 5 0 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P.. (dmp, ) (Entered: 11/03/2015)
2015-11-13 6 0 Joint STIPULATION and Order of Consolidation by Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Grunenthal GMBH, The P.F. Laboratories Inc.. (Smith, Rodger) (Entered: 11/13/2015)
2015-11-17 7 0 SO ORDERED - re (15 in 1:15-cv-00686-GMS, 20 in 1:15-cv-00687-GMS, 14 in 1:15-cv-00784-GMS, 9 in 1:15-cv-00940-GMS, 6 in 1:15-cv-01008-GMS) Joint Stipulation and Order of Consolidation. Cases are consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 15-687-GMS. Signed by Judge Gregory M. Sleet on 11/17/2015. Associated Cases: 1:15-cv-00686-GMS, 1:15-cv-00687-GMS, 1:15-cv-00784-GMS, 1:15-cv-00940-GMS, 1:15-cv-01008-GMS(mdb) (Entered: 11/18/2015)